EN DE
Watch Nrgene Technologies Ltd for free: once a week we email you where price and fair value stand.
Data-driven stock valuation

Nrgene Technologies Ltd (NRGN) fair value: what the stock is really worth

As of Nov 19, 2026: fair value (intrinsic value) of Nrgene Technologies Ltd stock ILS 1.25, price ILS 0.61, upside +103.9%, quality 55 out of 100. Rating: strongly undervalued. Calculated from audited financials with 7 of our 26 valuation models and 37 quality factors, updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Technology Il · ISIN IL0011720716

NT Nrgene Technologies Ltd logo Thin data Nov 19, 2026

Nrgene Technologies Ltd

NRGN · TA

Cheap (51% below fair value) and solid company, but falling price: meets 2 of 3 rules.

Follow free in the weekly email
Fair value 1.25 ILS · Strongly undervalued 
Low debt 
Generates free cash flow 
Even on cautious assumptions the value is 94% above the price (1.19 ILS). 
Quality 55/100 
Mixed vs. peers (5/10) 
Falling price (downtrend) 
Weak Growth (revenue 5y −14.7 %/yr in USD) 
Loss-making · -55.5% net margin (TTM) 
Narrow moat 14/100 · thin data
Thin data 
Watch Nrgene Technologies Ltd for free: once a week we email you where price and fair value stand. Watch for free

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

17.57 ILS 0.6050 ILS Fair Value 1.25 ILS Jul 2021 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 19, 2026.

How to read this chart

60‑month range 0.6050 ILS – 17.57 ILS · fair‑value band 1.19 ILS – 1.34 ILS · the 0.6130 ILS price screens below the 1.25 ILS fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 19, 2026.

Follow Nrgene Technologies in your weekly email

Every Wednesday you see whether Nrgene Technologies is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

NRGene Technologies Ltd operates as a research and development company focusing on intellectual property-intensive technological products in the field of AgTech in North America, Europe, the Middle East, Africa, Asia Pacific, and internationally.

Show moreShow less

It develops and commercializes plant varieties, traits, and animals based on artificial intelligence (AI) technology and software tools for analyzing genetic information.

The company also offers Supree semi-dried cherry tomatoes; clubroot-resistant canola; and black soldier fly as an alternative to animal-based protein. Its technology portfolio includes DeNovoMAGIC, a de novo assembly solution that assembles genomes.

NRGene Technologies Ltd was incorporated in 2009 and is based in Ness Ziona, Israel.

Stock analysis

Nrgene Technologies Ltd (NRGN) currently trades at 0.6130 ILS, while our model-based Fair Value estimate is 1.25 ILS, implying the stock looks roughly 51% undervalued today.

Show more

Valuation

Bull case: the Growth DCF group reads highest at a median of 1.27 ILS per share, and 6 of the 7 models we run sit above the 0.6130 ILS price.

Bear case: the Asset-Based group reads lowest at 0.2500 ILS, and 1 of the 7 models stay below the price. Data coverage for this calculation is low.

Scenario range: 1.19 ILS (bear) to 1.34 ILS (bull), the price of 0.6130 ILS sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 55/100 (solid quality), in the Technology sector.

Weak Growth: Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.

Nrgene Technologies Ltd reported revenue of $3.2M in FY2025 versus $4.5M in FY2021, a compound −8.2%/yr. Reported net income was −$1.5M in FY2025.

Key figures

Market cap 8.1M ILS Micro · P/S ratio 3.14 · EPS (TTM) −0.3700 ILS · Net margin −47.4% · Return on equity −74.9% · Return on assets (EBIT) −36.7% (5-year average) · Operating margin −537% · Revenue (TTM) $2.9M.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 14 out of 100 (low confidence).

What moves the price

The share trades about 79% below its 52-week high and 1% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Technology peers we cover trades at 13% fair-value upside, at 104%, NRGN screens cheaper than that median.

Fair Value models

Bear 1.19 ILS Fair Value 1.25 ILS Bull 1.34 ILS
Price 0.6130 ILS · Upside +103.9%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
FCF DCF 1.21 ILS 1.26 ILS 1.35 ILS 82
Growth DCF 1.21 ILS 1.27 ILS 1.34 ILS 80
5Y Revenue Exit 1.19 ILS 1.25 ILS 1.35 ILS 74
All 7 models by family
DCF Models
FCF DCF 1.21 ILS 1.26 ILS 1.35 ILS 82
5Y Revenue Exit 1.19 ILS 1.25 ILS 1.35 ILS 74
10Y Revenue Exit 1.19 ILS 1.24 ILS 1.29 ILS 68
Multiples
EV/Revenue 1.14 ILS 1.21 ILS 1.28 ILS 54
Asset-Based
NCAV (Graham) 0.1600 ILS 0.2500 ILS 0.3100 ILS 54
Growth DCF
Growth DCF 1.21 ILS 1.27 ILS 1.34 ILS 80
Rev-Margin DCF 1.19 ILS 1.26 ILS 1.34 ILS 74

Open the full fair value analysis →

Quality Score breakdown

Overall quality 55/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 11
How much profit the company makes from its sales and capital
Quality Growth 100
Are margins and returns getting better?
Cashflow 39
Do the profits arrive as real cash?
Financial strength 66
Debt, balance sheet and risk of trouble
Investment 67
Does it invest with discipline instead of growing at any price?
Low Volatility 59
How calm the share price moves, does not count
Price momentum 0
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 0
Distance to the 52-week high, does not count
New shares 72
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 18/100
Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Revenue growth 1 year
+145.7%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+0.1%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−14.7%
Start year 2020 (pandemic)
Revenue growth 7 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−11.3%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−24.4% (2020) → −49.5% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed

Growth Forecast

Little optimism in the price
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
less than -40 %
The company could shrink this much every year for the next five years and today's price would still be justified.
What forecasts expect
n/a
No analyst forecast available.

Watch NRGN, get fair value alerts →

Compare Nrgene Technologies Ltd with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Software - Application · 726 stocks

Beats the industry median on 4/8 measures
A mixed picture versus its industry peers.
Valuation
Quality Score 55 · Above median
Fair Value upside +103.9% · Top 25%
Profitability
Return on assets −15.7% · Bottom 25%
Net margin (12 months) −55.5% · Bottom 25%
Growth and dividend
Revenue growth (quarter YoY) −38.0% · Bottom 25%

Valuation Multiplesvs Software - Application median · lower = cheaper

P/B 0.57× · Cheapest 25%
P/S (12 months) 0.84× · Cheapest 25%
Price / free cash flow (fiscal year) 34.3× · Priciest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)100 · sector 30
FUTURE (revenue growth)0 · sector 42
PAST (return on equity)0 · sector 11
HEALTH (low debt)100 · sector 98
DIVIDEND (yield)0 · sector 28

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Software - Application stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Adobe Inc ADBE $226.20 $463.72 +105% vs NRGN
Salesforce, Inc CRM $190.40 $342.73 +80% vs NRGN
Uber Technologies, Inc UBER $68.76 $101.28 +47% vs NRGN
Intuit Inc INTU $313.24 $459.14 +47% vs NRGN
ServiceNow, Inc NOW $90.59 $102.19 +13% vs NRGN
SAP SE SAP €187.02 €173.59 −7% vs NRGN
Cadence Design Systems, Inc CDNS $305.82 $225.48 −26% vs NRGN
Automatic Data Processing, Inc ADP $305.57 $192.37 −37% vs NRGN
Shopify Inc SHOP $139.42 $64.96 −53% vs NRGN
Snowflake Inc SNOW $279.62 $74.50 −73% vs NRGN

Explore undervalued stocks

More undervalued Technology stocks →

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Nrgene Technologies Ltd: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "Nrgene Technologies Ltd Fair Value". https://www.fairvalue-calculator.com/stock/NRGN

Frequently asked questions

Is Nrgene Technologies Ltd (NRGN) overvalued or undervalued?
As of Nov 19, 2026, our model estimates a fair value of 1.25 ILS versus a price of 0.6130 ILS, about +104% upside (undervalued).
What is the fair value of NRGN?
Our model-based fair value for Nrgene Technologies Ltd is 1.25 ILS (as of Nov 19, 2026), built from audited fundamentals. The current price: 0.6130 ILS.
What is the quality score of NRGN?
Nrgene Technologies Ltd has a Quality Score of 55/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Nrgene Technologies Ltd (NRGN)?
We do not set a price target; the yardstick is the fair value of 1.25 ILS (as of Nov 19, 2026) from 7 valuation models. Cautious scenario 1.19 ILS, optimistic scenario 1.34 ILS. It is a calculation from audited fundamentals, not an analyst target.
What is the Nrgene Technologies Ltd stock forecast for 2026?
Our models put fair value at 1.25 ILS, about +104% upside versus a price of 0.6130 ILS (undervalued). Cautious scenario 1.19 ILS, optimistic scenario 1.34 ILS. The calculation is refreshed regularly with new filings.
What is the revenue of Nrgene Technologies Ltd (NRGN)?
Nrgene Technologies Ltd reported trailing-twelve-month revenue of about $2.9M (latest available figure, as of Nov 19, 2026).
What growth is priced into Nrgene Technologies Ltd (NRGN)?
Today's price is already fair in a discounted-cash-flow model if free cash flow at Nrgene Technologies Ltd shrinks by more than 40 % per year for five years (discount rate 11.6 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue fell 14.7 % per year. As of Nov 19, 2026.
What discount rate (WACC) does the fair value of NRGN use?
Our models discount Nrgene Technologies Ltd at 11.6 %: a base by market capitalisation (nano), country premium for Israel. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Nrgene Technologies Ltd that is less than minus 40 % per year for five years, then slowing evenly to 2 % by year ten, using the same discount rate (11.6 %) and the same formula as our fair value.
How much growth has Nrgene Technologies Ltd (NRGN) delivered so far?
Over the past 5 years revenue at Nrgene Technologies Ltd shrank 14.7 % a year. The price currently implies free-cash-flow growth of less than minus 40 % per year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Nrgene Technologies Ltd (NRGN) growing?
The median revenue growth in the sector is +12.1 % a year. That is the yardstick for the growth priced into Nrgene Technologies Ltd (less than minus 40 % per year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Nrgene Technologies Ltd (NRGN)?
The free-cash-flow yield on the price is 2.94 %: that much free cash flow Nrgene Technologies Ltd produces per unit of market value. When it exceeds the discount rate of our models (11.6 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Nrgene Technologies Ltd (NRGN)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Nrgene Technologies Ltd it is 1.25 ILS per share (as of Nov 19, 2026), against a price of 0.6130 ILS. It is the blended result of 7 valuation models in 4 families (DCF Models, Multiples, Asset-Based, Growth DCF).
Is Nrgene Technologies Ltd stock overvalued or undervalued in 2026?
As of Nov 19, 2026, NRGN trades below its calculated fair value: price 0.6130 ILS, fair value 1.25 ILS, a gap of about +104% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of NRGN?
No. The price is what the market pays today (0.6130 ILS); the fair value is what the company's own numbers justify (1.25 ILS). For Nrgene Technologies Ltd the two are 0.6370 ILS per share apart. That gap is exactly why we show both numbers side by side.
How much is Nrgene Technologies Ltd worth?
The market values Nrgene Technologies Ltd at about 8.1M ILS (market capitalisation, as of Nov 19, 2026). Per share that is 0.6130 ILS; our models calculate a fair value of 1.25 ILS per share.
What do the bullish and bearish scenarios say about NRGN?
Our models span a range for Nrgene Technologies Ltd: cautious scenario 1.19 ILS, base 1.25 ILS, optimistic 1.34 ILS per share (as of Nov 19, 2026, price 0.6130 ILS). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Nrgene Technologies Ltd (NRGN)?
Balance-sheet figures for Nrgene Technologies Ltd (as of Nov 19, 2026): return on equity −74.9%. They feed the Quality Score of 55/100, which measures business quality independently of the share price.
How far is NRGN from its 52-week high?
Nrgene Technologies Ltd trades at 0.6130 ILS, about 79% below its 52-week high of 2.98 ILS and 1% above the low of 0.6050 ILS (as of Nov 19, 2026). Distance from the high says nothing about value: that is what the fair value of 1.25 ILS is for.
Which stocks are comparable to Nrgene Technologies Ltd?
From the same area (Technology) we also value SAP SE, Shopify Inc, Salesforce, Inc, ServiceNow, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Nrgene Technologies Ltd stock attractive at the current price?
The data as of Nov 19, 2026: price 0.6130 ILS, calculated fair value 1.25 ILS (+104%), Quality Score 55/100, from 7 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of NRGN calculated?
We run Nrgene Technologies Ltd through 7 models from 4 families: DCF Models, Multiples, Asset-Based, Growth DCF. Every model gets the same audited fundamentals; the fair value of 1.25 ILS builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 12.0% above its aggregate fair value. Nrgene Technologies Ltd currently trades 51% below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Nrgene Technologies Ltd (NRGN)?
The closing price on Nov 19, 2026 was 0.6130 ILS. Our model-based fair value is 1.25 ILS, about +104% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Nrgene Technologies Ltd right now?
The price is below even our cautious bear case (1.19 ILS). The market is more pessimistic than our downside scenario. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. Solid quality (55/100) at a price below fair value, the discount is the argument here, not the business quality. The models converge in a tight band (1.19 ILS to 1.34 ILS), unusually little disagreement for a valuation.

Key figures of Nrgene Technologies Ltd

How large is the market capitalisation of Nrgene Technologies Ltd (NRGN)?
The market capitalisation of Nrgene Technologies Ltd is 8.1M ILS. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Nrgene Technologies Ltd (NRGN)?
The price-to-sales ratio of Nrgene Technologies Ltd is 3.14 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Nrgene Technologies Ltd (NRGN)?
Earnings per share at Nrgene Technologies Ltd are −0.3700 ILS. Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Nrgene Technologies Ltd (NRGN)?
The net margin of Nrgene Technologies Ltd is −47.4% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Nrgene Technologies Ltd (NRGN)?
The return on equity (ROE) of Nrgene Technologies Ltd is −74.9% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Nrgene Technologies Ltd (NRGN)?
On an EBIT basis the return on assets of Nrgene Technologies Ltd is −36.7% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Nrgene Technologies Ltd (NRGN)?
The operating margin of Nrgene Technologies Ltd is −537% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Nrgene Technologies Ltd (NRGN)?
Revenue at Nrgene Technologies Ltd is down 38.0% versus a year earlier (3y avg +0.1%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much net cash does Nrgene Technologies Ltd (NRGN) hold?
Nrgene Technologies Ltd holds more cash than debt, $4.0M net (fiscal year 2025). The company holds more cash than debt, a safety cushion.
Free · no account needed

Watch Nrgene Technologies Ltd in the live analysis

One click puts Nrgene Technologies Ltd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.